Form D · Pharmaceuticals

Novelix Pharmaceuticals Inc

La Jolla, CA · CIK 0001333263

Offering snapshot reported Oct 26, 2009 · SEC filing

Reported sold
$253K
Offering amount: $1.75M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 8, 2009
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 26, 2009Initial$253,103No comparison10SEC filing
Aug 26, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Dec 12, 2007PaperNot reportedNo comparisonNot reportedSEC filing
May 8, 2006PaperNot reportedNo comparisonNot reported
Jul 14, 2005PaperNot reportedNo comparisonNot reportedSEC filing
Jul 8, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-79381
Offering of Series A-5 Preferred Stock and the underlying shares of Common Stock issued upon the conversion thereof.

Source: Form D, filed Oct 26, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Burkhard Jansen Director, Executive
Jeremy Teraoka Director, Executive
Timothy Triche Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
8008 Girard Ave. Suite 330
La Jolla, CA, 92037